These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1055150)

  • 1. Clinical situations in which amputation is preferred to pulp capping because of biologic considerations.
    Berk H; Krakow AA; Stanley HR
    J Am Dent Assoc; 1975 Apr; 90(4):801-5. PubMed ID: 1055150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reaction of the exposed pulp to Dycal treatment.
    Tronstad L
    Oral Surg Oral Med Oral Pathol; 1974 Dec; 38(6):945-53. PubMed ID: 4216870
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytotoxic effects and pulpal response caused by a mineral trioxide aggregate formulation and calcium hydroxide.
    de Souza Costa CA; Duarte PT; de Souza PP; Giro EM; Hebling J
    Am J Dent; 2008 Aug; 21(4):255-61. PubMed ID: 18795523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Permeability of the hard tissue bridge formed after pulpotomy with calcium hydroxide: a histologic study.
    Holland R; de Souza V; de Mello W; Nery MJ; Bernabé PF; Otoboni Filho JA
    J Am Dent Assoc; 1979 Sep; 99(3):472-5. PubMed ID: 112134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Calcium hydroxide in endodontic therapy. 1].
    Goracci G; Cantatore G
    Dent Cadmos; 1989 Sep; 57(14):17, 19-20, 23 passim. PubMed ID: 2638254
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pulp-dentin therapy: the various possibilities for capping].
    Lesous J; Mathieu R; Brouillet JL
    Rev Fr Endod; 1986 Mar; 5(1):73-89. PubMed ID: 3474726
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of Recombinant Human Platelet-Derived Growth Factor or Enamel Matrix Derivative Plus Calcium Hydroxide for Pulp Capping: A Randomized Controlled Human Clinical Trial.
    Al-Hezaimi K; Naghshbandi J; Alhuzaimi R; Alonaizan F; AlQwizany I; Rotstein I
    Int J Periodontics Restorative Dent; 2020; 40(5):645-654. PubMed ID: 32925992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of calcium hydroxide-containing pulp-capping agents on pulp cell migration, proliferation, and differentiation.
    Schröder U
    J Dent Res; 1985 Apr; 64 Spec No():541-8. PubMed ID: 3857254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulpal reactions to dental caries.
    Massler M
    Int Dent J; 1967 Jun; 17(2):441-60. PubMed ID: 5233875
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical situations in which amputation is preferred to pulp capping because of biologic considerations.
    Berk H; Krakow AA; Stanley HR
    Oral Health; 1975 Dec; 65(12):26-8. PubMed ID: 1074130
    [No Abstract]   [Full Text] [Related]  

  • 11. Pulpal and periapical response of dogs' teeth after pulpotomy and use of recombinant human bone morphogenetic protein-7 as a capping agent.
    da Silva LA; de Paula e Silva FW; Leonardo MR; Assed S
    J Dent Child (Chic); 2007; 74(2):79-84. PubMed ID: 18477424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dental pulp capping: effect of Emdogain Gel on experimentally exposed human pulps.
    Olsson H; Davies JR; Holst KE; Schröder U; Petersson K
    Int Endod J; 2005 Mar; 38(3):186-94. PubMed ID: 15743422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological, ultrastructural and quantitative investigations on the response of healthy human pulps to experimental capping with mineral trioxide aggregate: a randomized controlled trial.
    Nair PN; Duncan HF; Pitt Ford TR; Luder HU
    Int Endod J; 2008 Feb; 41(2):128-50. PubMed ID: 17956562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravital treatment of the pulp with simultaneous laser biostimulation.
    Dabrowska E; Zdanowicz-Wiloch J; Pawińska-Magnuszewska M; Stokowska W
    Rocz Akad Med Bialymst; 1997; 42(1):168-76. PubMed ID: 9581476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodentine used as a pulp-capping agent in primary pig teeth.
    Shayegan A; Jurysta C; Atash R; Petein M; Abbeele AV
    Pediatr Dent; 2012; 34(7):e202-8. PubMed ID: 23265156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vital pulp therapy with new materials: new directions and treatment perspectives--permanent teeth.
    Witherspoon DE
    J Endod; 2008 Jul; 34(7 Suppl):S25-8. PubMed ID: 18565368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vital pulp therapy with new materials: new directions and treatment perspectives--permanent teeth.
    Witherspoon DE
    Pediatr Dent; 2008; 30(3):220-4. PubMed ID: 18615987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of bioactive molecules in pulp-capping situations.
    Goldberg M; Six N; Decup F; Buch D; Soheili Majd E; Lasfargues JJ; Salih E; Stanislawski L
    Adv Dent Res; 2001 Aug; 15():91-5. PubMed ID: 12640750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiographic evaluation of pulpal and periapical response of dogs' teeth after pulpotomy and use of recombinant human bone morphogenetic protein-7 as a capping agent.
    da Silva LA; de Paula e Silva FW; Leonardo MR; Assed S
    J Dent Child (Chic); 2008; 75(1):14-9. PubMed ID: 18505642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of pulpotomy wounds in normal human teeth to successively applied Ledermix and Calxyl.
    Ulmansky M; Sela J; Langer M; Yaari A
    Arch Oral Biol; 1971 Dec; 16(12):1393-8. PubMed ID: 5291490
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.